Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure
- PMID: 2142949
Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure
Abstract
This study was performed to investigate the effects of atrial natriuretic peptide (ANP) and mannitol on renal blood flow (RBF) and radiocontrast-induced nephropathy (RCIN) in human subjects with chronic renal failure. ANP preserves glomerular filtration rate or RBF (or both) in severe animal models of acute renal failure. Radiocontrast is known to substantially decrease RBF and can induce acute renal failure. Twenty consecutive patients with chronic renal failure (60% with diabetes) were randomized in a prospective, double-blind fashion to receive either ANP (50 micrograms bolus, then 1 microgram/min infusion) or mannitol (15% at 100 ml/hr) for 2 hours before and during cardiac catheterization with diatrizoate. Baseline serum creatinine level (ANP 2.4 +/- 0.7 mg/dl, mannitol 2.5 +/- 0.8 mg/dl), medications, and quantity of radiocontrast were similar in both groups. Direct measurements of RBF were made with thermodilution catheters placed in the left renal vein. RBF rose significantly (p less than 0.05), to 198% of baseline at 15 minutes and 166% of baseline at 65 minutes in the group receiving ANP and remained stable in the group receiving mannitol. ANP levels rose significantly from baseline at 5, 15, 65 and 120 minutes in both groups (p less than 0.05). Acute renal failure defined as a 0.5 mg/dl rise of creatinine within 24 hours of cardiac catheterization, developed only in patients with diabetes mellitus and was similar in both experimental groups (ANP, 50%; mannitol, 30%). Only patients with diabetes mellitus responded with an increase in RBF after a 5-minute infusion of either ANP or mannitol (diabetes, 165% +/- 28% baseline; no diabetes, 96% +/- 8% baseline) (p less than 0.05). In conclusion, RBF was maintained or increased despite administration of radiocontrast, a documented renal vasoconstrictor. Patients with diabetes mellitus had a renal vasodilatory response to drug infusion. Acute renal failure occurred to a similar extent in both groups. Plasma ANP levels rose significantly in both groups. Mannitol may induce ANP release, thus contributing to mannitol's renal effects.
Similar articles
-
Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy.Am J Kidney Dis. 1998 Apr;31(4):674-80. doi: 10.1053/ajkd.1998.v31.pm9531185. Am J Kidney Dis. 1998. PMID: 9531185 Clinical Trial.
-
Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide.J Am Coll Cardiol. 2009 Mar 24;53(12):1040-6. doi: 10.1016/j.jacc.2008.10.061. J Am Coll Cardiol. 2009. PMID: 19298916 Clinical Trial.
-
Measurement of changes in glomerular filtration rate induced by atrial natriuretic peptide in the rat kidney.Exp Physiol. 1999 Jul;84(4):689-96. Exp Physiol. 1999. PMID: 10481226
-
Radiocontrast-induced nephropathy: current status and future prospects.Int Angiol. 1992 Jan-Mar;11(1):20-5. Int Angiol. 1992. PMID: 1387889 Review.
-
Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography.Am J Med. 1990 Nov;89(5):615-20. doi: 10.1016/0002-9343(90)90180-l. Am J Med. 1990. PMID: 2239981 Review.
Cited by
-
Low-dose atrial natriuretic peptide for prevention or treatment of acute kidney injury: a systematic review and meta-analysis.Crit Care. 2019 Feb 11;23(1):41. doi: 10.1186/s13054-019-2330-z. Crit Care. 2019. PMID: 30744687 Free PMC article.
-
Examining Mannitol Use in Kidney Cancer Surgery: A Cautionary Tale of Extrapolated Surgical Data.Eur Urol Focus. 2019 Nov;5(6):930-934. doi: 10.1016/j.euf.2019.09.021. Epub 2019 Oct 15. Eur Urol Focus. 2019. PMID: 31628080 Free PMC article.
-
Effects of mannitol alone and mannitol plus furosemide on renal oxygen consumption, blood flow and glomerular filtration after cardiac surgery.Intensive Care Med. 2009 Jan;35(1):115-22. doi: 10.1007/s00134-008-1206-5. Epub 2008 Jul 9. Intensive Care Med. 2009. PMID: 18612627 Clinical Trial.
-
Pharmacological strategies to prevent contrast-induced acute kidney injury.Biomed Res Int. 2014;2014:236930. doi: 10.1155/2014/236930. Epub 2014 Feb 26. Biomed Res Int. 2014. PMID: 24719848 Free PMC article. Review.
-
Intravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized Trial.Eur Urol. 2018 Jan;73(1):53-59. doi: 10.1016/j.eururo.2017.07.038. Epub 2017 Aug 16. Eur Urol. 2018. PMID: 28822586 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical